The effect of experimental trypanosomiasis on coagulation was studied because a patient in this hospital with Rhodesian trypanosomiasis developed thrombocytopenia with disseminated intravascular coagulation. Rats injected intraperitoneally with this strain of Trypanosoma rhodesiense consistently developed trypanosomiasis and severe thrombocytopenia without changes in hematocrit or concentration of fibrinogen or fibrin split products. At the time of 50% mortality (4-5 days) mean platelet counts per cubic millimeter of infected rats were 18,000±9,000 (±2 SEM) compared to 1,091,000±128,000 in uninfected controls.
INTRODUCTION
We studied the effect of experimental trypanosomiasis on coagulation factors because a patient in this hospital with Rhodesian trypanosomiasis almost died of disseminated intravascular coagulation (DIC)' (1) . Various An abstract of a portion of this work appeared in Clin. Res. 1973 . 21: 269.
Received for publication 16 July 1973 and in revised form 2 November i973. 1 Abbreviations used in this paper: DIC, disseminated severe infections may cause DIC, but it is usually associated with meningococcemia or septicemia due to gram-negative bacilli. Among the protozoan infections only severe falciparum malaria is well documented as a cause of this syndrome (2, 3) .
We were surprised to find that 100% of rats infected with this Rhodesian strain developed severe thrombocytopenia without evidence of hemolysis or DIC. This dissociation of thrombocytopenia from DIC strongly indicates a direct toxic effect of the trypanosomes on platelets. Although it has been speculated that Plasmodium vivax may produce circulating toxins directly harmful to platelets (4) , most studies suggest that the thrombocytopenia associated with malaria is due to DIC (2, 3), immunologic injury (5), or splenic pooling (6) . In bacterial septicemias the thrombocytopenia is clearly associated with DIC (7) .
In this study we reproduced platelet injury in vitro by whole trypanosomes and with soluble extracts of disrupted trypanosomes. Since the process is independent of immune complexes and complement and is not blocked by inhibitors of ADP or kinins, it appears to represent a new mechanism of microbial injury of platelets and thrombocytopenia.
METHODS
Experimental trypanosomiasis. Male 200-g Holtzman rats or 2.5-3.0 kg white New Zealand rabbits were injected i.p. with a 0.15 M NaCl dilution of infected, fresh rat blood containing 10-20,000 trypanosomes, or more than 1,000 infective doses for rats. Syringe-passed trypanosomes maintained in rats were used in all experiments. During the first few passages this strain of T. rhodesiense became more virulent for rats, but the clinical syndrome and time of LDwoo has been stable for 1 yr. Control animals received either an equal volume of normal rat blood or nothing.
Normal rat blood caused no visible illness and no blood intravascular coagulation; EM, electron microscopy; FSP, fibrin and fibrinogen split products; HCT, hematocrit; changes. Studies on splenectomized rats were performed after wounds were well healed and platelet counts had returned toward normal. Rabbits congenitally deficient in C6 were infected in the usual manner. Rats were exsanguinated by cardiac puncture at the time of study. Rabbits were bled from the central artery of the ear. Autopsies were performed on 18 rats at the time of 50% mortality. Serial sections of formaldehyde-fixed kidneys, livers, spleens, lung, hearts, and brains were stained with hematoxylin and eosin and by the periodic-acid Schiff method.
Hematological studies. Platelets and trypanosomes were counted by phase microscopy. Occasionally, nonmotile trypanosomes assume a spherical shape but can still be differentiated from platelets by careful observation. Microhematocrits (HCT) were determined by centrifugation of EDTAtreated blood in capillary tubes. Fibrinogen was measured by the method of Ratnoff and Menzie (8) but with citrated blood, and split products of fibrin and fibrinogen (FSP) were estimated by the staphylococcal clumping technique (9) . The details of these procedures have been described in another publication (10) .
In vitro platelet aggregation. Normal rat, rabbit or human blood was harvested in 0.008 mg/ml EDTA (EDTA: blood = 1: 9; vol: vol). Blood from infected rats was harvested either in EDTA or 0.38 mg/ml sodium citrate (1: 9; vol: vol). Unless otherwise noted, EDTA and sodium citrate were always used at these standard anticoagulating concentrations. Trypanosomes were harvested from a visible layer on top of the buffy coat of infected rat blood and stored at 40C until use. These concentrated trypanosomes were platelet-poor and contained no platelet aggregates.
To 1 ml of normal blood harvested in EDTA, 0.1 ml of concentrated trypanosomes (W10-107/mm3) or 0.1 ml of normal, species-specific plasma was added. The tubes were rocked continuously at 36 oscillations/min on an Ames aliquot mixer (Ames Co., Div. of Miles Lab, Inc., Elkhart, Ind.) at room temperature, and platelet counts and other determinations were performed at 30 min. All platelets that could be counted accurately were incorporated in the tally, including platelets in small aggregates of four or five.
Investigation of the mechanism of platelet injury. The response of the platelet counts of infected animals to increasing trypanosomemia was measured by infecting 36 rats and exsanguinating at least 6 daily. Trypanosomes and platelets were counted by phase microscopy, and the results were plotted as platelet counts versus trypanosome counts.
Six littermates were used as the normal controls. The "doseresponse" relationship of the aggregation phenomenon was measured by noting the effect of 0.1 ml of serial 10-fold dilutions of trypanosomes (8.8 X 10W/mm3, 8.8 X 105/mm3, and 8.8 X 104/mm') on 1 ml of a pool of normal rat blood. The negative control consisted of 0.1 ml of normal plasma harvested from the same pool of rat blood.
Platelet aggregation was tested under several experimental situations designed to elicit the nature of the mediator of trypanosome-induced aggregation. It was likely that fairly large amounts of exogenous ADP from the trypanosomes and rat red cells were added to normal blood during the in vitro aggregation experiments. Accordingly, very large concentrations of ADP (up to 60 mg/ml) were added to the EDTA-treated normal blood instead of trypanosomes. The ability of trypanosomes to induce platelet aggregation in whole blood or platelet-rich plasma (PRP) pretreated with 50 mM adenosine was determined. Exogenous ADP was also removed by dialyzing the harvested trypanosomes overnight against phosphate-buffered saline and by separating the trypanosomes from rat blood in a QAE-50 Sephadex column with a phosphate-buffered salineglucose (PSG) solution (11) . Dialyzed trypanosomes and column trypanosomes, which were completely free of rat erythrocytes and platelets, were washed with 10 vol of PSG, diluted to 8 X 106/mm', and tested for the aggregating effect as described above. In order to test whether complement components were required for trypanosome-induced platelet aggregation, the blood of rabbits congenitally deficient in C6 was drawn into 0.2 M EDTA, a concentration sufficient to inactivate C4 and C2, and the usual concentration of trypanosomes was added.
Participation of kininlike substances in the platelet injury was checked by adding trypsin (50-500 jug/ml), alphachymotrypsin (50-500 ug/ml), or an equal volume of saline to harvested trypanosomes for 30 min at 370C. Lima bean trypsin inhibitor was then added to each sample of trypanosomes before addition of 0.1 ml of the treated trypanosomes to 1.0 ml of rat blood. The effect of washing the trypanosomes before addition to normal blood was tested by washing the harvested trypanosomes from an aliquot of plasma three times in 10 vol of 0.15 M NaCl. In the in vitro system, the washed trypanosomes, the trypanosome-free infected plasma concentrated five times, and the washings reduced in volume at 4°C in dialysis tubing to only twice the original plasma volume were tested for their ability to cause platelet aggregation.
1 ml of trypanosomes (l10) harvested from rat blood was sonicated in ice by means of a biosonic probe with one or two 10-s bursts at 30% intensity. This short period disrupted approximately 90-95% of the trypanosomes. The sonicated material was then made trypanosome-free by centrifugation at 3,500g for 20 min. 1 ml each of the untreated supernate, supernate preheated at 56°C for 30 min, and supernate treated with trypsin or alpha-chymotrypsin was added to 1 ml of normal rat blood.
Electron microscopy (EM). Column-purified trypanosomes or trypanosome-free sonicate were added to tubes of citrated rat PRP and gently rocked at room temperature. Samples were withdrawn at 30 min and 90 min for fixation and preparation for EM, along with control samples of PRP.
For transmission EM the samples were added to equal volumes of 0.2% glutaraldehyde in isotonic buffered saline (IBS) centrifuged at 1,500g for 15 min to form a loose pellet, fixed in 2% glutaraldehyde in IBS for 2 h, postfixed in 2% osmium tetroxide in IBS for 1 h, dehydrated, and embedded in Araldite (Ciba Products Co., Summit, N. J.). Sections were cut with a Porter-Blum MT-2B ultramicrotome and stained with lead citrate and uranyl acetate. They were examined with a Zeiss 9S electron microscope (Carl Zeiss, Inc., New York).
For scanning EM samples were pipetted onto glass cover slips and fixed in place with 0.2%o glutaraldehyde in IBS for 15 min, followed by 2%o glutaraldehyde in IBS for 1 h. After dehydration in an ethanol-Freon series and processing in a Bomar SPC-900 critical point drying apparatus (The Bomar Co., Tacoma, Wash.), they were mounted on aluminum studs, coated with a 400-600-A layer of gold-palladium, and examined with an Etec U-1 scanning electron microscope (Etec Corp., Hayward, Calif.). 
RESULTS

Experimental trypanosomiasis
More than 500 rats and 50 rabbits were studied. All infected rats died between 96 and 144 h with no obvious signs of illness until shortly before death. Rabbits followed a more erratic course and died after a cachetic illness of 3-6 wk. The effect of experimental trypanosomiasis on the platelet count, Hcr, and fibrinogen was determined 96 h after infection (24 h before the first spontaneous death occurred) and at 120 h, the death point in rats not subjected to blood studies. As shown in a typical experiment in Table I , the Hcr and fibrinogen concentrations of infected rats did not differ from uninfected controls. The platelet counts, on the other hand, were markedly reduced in infected rats at 96 h and again fell sharply during the 24 h before death, when the number of trypanosomes in the blood was increasing rapidly. In fact an inverse relationship between the number of trypanosomes and platelets suggested a direct effect of trypanosomes or their products on the platelets. No platelet aggregates were ever noted in the platelet counts performed during the in vivo experiments.
Next a group of rats were studied daily to be certain that DIC with early consumption of fibrinogen and production of FSP was not responsible for the thrombocytopenia that occurred late in the disease. The range of FSP in more than 25 normal rats was 2-16 tg/ml with a mean of 8 /g/ml +0.68 (2 SEM). When three different rats were studied daily ( Fig. 1) To rule out the possibility that the thrombocytopenia occurred in vitro by reaction of intact trypanosomes and platelets between the time of exsanguination and the platelet count, six infected rats were treated with suramin (3 mg/kg) 24 h before the estimated time of death. When they were exsanguinated 24 h later, the trypanosomemia had cleared, but striking thrombocytopenia persisted with a mean platelet count of 128+62 X 10' platelet/mm' (±2 SEM) and was nearly as severe Holtzman male rats (200-250 g) were splenectomized under ether anesthesia. 4 wk later when the platelet counts were approaching normal, 15 rats were infected intraperitoneally with 10,000 trypanosomes. When 50% of the infected rats had died (5 days), five infected rats and five uninfected, splenectomized rats were exsanguinated and studied. All infected, splenectomized rats died within 144 h. Values are AtSEM. as that of six infected littermates bled 24 h earlier (62 ±36 X 10) at the time the treated rats were given suramin. Suramin (3 mg/kg) did not alter the platelet count of six uninfected rats (1,053±60 X 10') compared to six untreated littermates (1,042±40 X 10'). This experiment did not rule out an effect of circulating trypanosomal products on platelets.
In vitro platelet aggregation Addition of 107 to 10" trypanosomes to 1 ml of normal rat blood invariably caused platelet aggregation in vitro.
Nonmotile trypanosomes stored in the refrigerator for up to 1-2 wk were as effective as fresh, motile trypanosomes. A typical experiment is shown in Table III . After 30 min most of the platelets were found in aggregates of greater than 10, and aggregates of 50 were not uncommon. As shown in Table III Platelet count X 103/mm3 Platelet counts from pooled blood of five rats. After harvesting, trypanosomes were treated with the indicated concentration of trypsin or alpha-chymotrypsin for 30 min at 370C. Trypsin was inactivated by lima bean trypsin inhibitor before trypanosomes were added to the rat blood. Note that the lima bean trypsin inhibitor also had no effect on aggregation. Platelets were counted at 30 min as outlined in the text and in Table III. plasma or heparinized plasma. At this concentration adenosine is a powerful inhibitor of ADP-induced platelet aggregation (13); (c) removal of ADP from trypanosome concentrates by dialysis and Sephadex QAE-50 did not alter the aggregating effect. At the same concentration of trypanosomes (8 X 106/mm3), aggregation resulted in platelet counts of 28 X 10'/mm' with the usual buffy coat trypanosomes, 34 X 103 with dialyzed trypanosomes, and 26 X 103 with column trypanosomes. The plasma control was 1,100 X 103/mm3. Complement inhibition. Because immune complexes in the presence of complement may cause platelet aggregation, we tested this possibility in vitro by the following experiment. The blood of rabbits congenitally deficient in C6 was drawn into 0.2 M EDTA, a concentration sufficient to inactivate C4 and C2. In this system immune lysis requiring all late components of C and immune adherence requiring the first four components would be completely blocked. As shown in Table IV , platelet aggregation is not mediated by complement.
Proof that the in vivo thrombocytopenia was also independent of the late components of complement at least was obtained by checking for thrombocytopenia in infected C6-deficient rabbits. Two rabbits congenitally EM. Scanning and transmission electron micrographs were made of aggregates induced by whole trypanosomes and trypanosome-free supernate. Fig. 4 shows the typical appearance on scanning EM of an aggregate induced by the trypanosome-free supernate. Fig. 5 compares normal platelets and aggregated platelets by transmission EM. These aggregates show typical changes of aggregation, including degranulation, centralization of granules, presence of micelles, and reduction in cytoplasmic density.
DISCUSSION
Severe thrombocytopenia occurs in rats and rabbits infected with this human strain of Trypanosoma rhodesiense. Since it occurs without consumption of fibrinogen or release of FSP (Table I and Fig. 1) , it is clear that the thrombocytopenia is not secondary to DIC. Instead a direct injury of platelets by trypanosomes appears responsible. Direct injury was first suggested by the inverse relationship of parasitemia to thrombocytopenia (Fig. 2) . The degree of platelet aggregation caused by the addition of trypanosomes in vitro to normal rat, rabbit, or human blood (Table III and IIIA) was directly related to the number of trypanosomes (Fig. 3) and stimulated a search for a trypanosomal factor capable of causing direct platelet damage. After it was shown that the in vitro aggregation was not caused by ADP derived from trypanosomes or red cells, this system became a simple assay for FIGURE 4 Platelet aggregate (at 90 min) induced by trypanosome-free supernate X 2,900 (scanning EM). studying the mechanism of platelet injury. A series of experiments with this system, supplemented by the in vivo model, has ruled out immunologic injury as the cause of platelet damage and shown that the aggregation is caused by a substance found in heat-labile supernates of disrupted trypanosomes.
It was necessary to study immunologic phenomena carefully because a series of reports have implicated the participation of antigen-antibody complexes in the pathogenesis of the lesions of trypanosomiasis. First, in experimental rabbit trypanosomiasis, each wave of parasitemia is caused by trypanosomes with antigens different from those of the predecessors, against which antibody has already been produced (16) . Second, Goodwin and Hook (17) have shown that the major pathologic changes in rabbits infected with Trypanosonta brucei are vascular lesions, thrombus formation, and increased vascular permeability. Finally, kinin concentrations are increased in experimental infections of laboratory animals (18) and volunteers (19) . Thus it has been postulated that the vascular pathology is related to the release of kinins by antigen-antibody complexes. Our studies suggest an alternative mechanism of vascular damage by showing that trypanosome mediated platelet injury is independent of immune complexes as mediated by immune adherence (Table IV) , complement-mediated lysis (Table IV) , and kinins (Table V) .
Independence from late components of complement was also shown by demonstrating that infected C6-deficient rabbits also developed thrombocytopenia. It is not known whether the trypanosomes in Goodwin and Thrombocytopenia in Experimental Trypanosomiasis 1365
brains of rats infected with our strain of T rhodesiense has not demonstrated such vascular lesions or fibrin deposition. Splenomegaly is the only finding. As shown in Table VI , remarkable platelet aggregation is produced by trypanosome-free extracts of disrupted organisms. The aggregating substance is so labile that it is inactivated by sonication lasting as little as 20 s beyond the initial 20-s period. The fact that it is heat-labile but not blocked by inhibitors of complement strongly suggests that it is a protein toxin or enzyme. The identity of this substance has not been determined. Among the agents known to cause platelet aggregation, ADP, antigen-antibody complexes, and FSP have been ruled out. Serotonin and epinephrine are unlikely because of the marked lability of the phenomenon to heat and sonication. Long-chained saturated fatty acids seem to be eliminated because the aggregating substance was not removed from supernates by extraction with petroleum ether.2 The trypanosomes may contain a protein with thrombin, fibrinogen, or collagen activity or a trypanosomal protein unrelated to other aggregating substances. Larger quantities of the thrombocytopenic factor are being accumulated for studies in vivo with the aggregating substance and in vitro with protein and enzyme inhibitors and isolation of the aggregating substance.
Thrombocytopenia has not been reported previously in experimental trypanosomiasis and indeed in only two cases of naturally acquired human trypanosomiasis (1, 20) . Both patients were Americans who visited endemic areas of Africa. It is important to know whether thrombocytopenia is a uniform accompaniment of Rhodesian trypanosomiasis, because the usual cause of death in this fulminating disease is unknown. Our data suggest that thrombocytopenia may be an important manifestation of this illness.
The platelet injury described here is independent of hemolysis, DIC, or immunologic injury related to immune adherence, complement-mediated lysis, or release of kinins. Aggregation of platelets in vitro by heatlabile supernates of disrupted trypanosomes is not blocked by inhibitors of complement or ADP. If the platelet effect is due to a protein toxin or enzyme, this will be the first infectious agent shown to have a direct toxic effect on the platelet without DIC. Release of procoagulants from injured platelets might then result in intravascular clotting in some animal species and account for the DIC observed in the patient treated in this hospital.
Note added in proof. After this manuscript was completed, our observation of thrombocytopenia in human trypanosomiasis was confirmed in rhesus monkeys by Sadun,
